company background image
R1MD34 logo

ResMed BOVESPA:R1MD34 Stock Report

Last Price

R$245.00

Market Cap

R$143.6b

7D

1.2%

1Y

n/a

Updated

28 Mar, 2024

Data

Company Financials +

R1MD34 Stock Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

R1MD34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends0/6

ResMed Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ResMed
Historical stock prices
Current Share PriceUS$245.00
52 Week HighUS$280.00
52 Week LowUS$183.79
Beta0.65
1 Month Change5.99%
3 Month Changen/a
1 Year Changen/a
3 Year Change-5.48%
5 Year Changen/a
Change since IPO44.88%

Recent News & Updates

Recent updates

Shareholder Returns

R1MD34BR Medical EquipmentBR Market
7D1.2%-0.6%-1.6%
1Yn/a9.0%18.9%

Return vs Industry: Insufficient data to determine how R1MD34 performed against the BR Medical Equipment industry.

Return vs Market: Insufficient data to determine how R1MD34 performed against the BR Market.

Price Volatility

Is R1MD34's price volatile compared to industry and market?
R1MD34 volatility
R1MD34 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.7%
Market Average Movement4.7%
10% most volatile stocks in BR Market7.9%
10% least volatile stocks in BR Market2.3%

Stable Share Price: R1MD34 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine R1MD34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
198910,140Mick Farrellhttps://www.resmed.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.

ResMed Inc. Fundamentals Summary

How do ResMed's earnings and revenue compare to its market cap?
R1MD34 fundamental statistics
Market capR$143.63b
Earnings (TTM)R$4.43b
Revenue (TTM)R$22.43b

32.4x

P/E Ratio

6.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
R1MD34 income statement (TTM)
RevenueUS$4.50b
Cost of RevenueUS$1.99b
Gross ProfitUS$2.52b
Other ExpensesUS$1.63b
EarningsUS$890.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)6.06
Gross Margin55.86%
Net Profit Margin19.77%
Debt/Equity Ratio27.4%

How did R1MD34 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.